Cord blood is the optimal graft source for the treatment of pediatric patients with lysosomal storage diseases: clinical outcomes and future directions-Reference-Cited by-同舟云学术

Cord blood is the optimal graft source for the treatment of pediatric patients with lysosomal storage diseases: clinical outcomes and future directions

Published:2015-06 Issue:6 Volume:17 Page:765-774
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Aldenhoven Mieke,Kurtzberg Joanne

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference62 articles.

1. Transplantation of umbilical cord blood in Fanconi’s anemia;Gluckman;Nouv Rev Fr Hematol,1990

2. CIBMTR Working Committee for Metabolic and Immune Deficiency Disorders. http://www.cibmtr.org. 2014.

3. The Mucopolysaccharidosis;Neufeld,2001

4. Musculoskeletal manifestations of lysosomal storage disorders;Aldenhoven;Ann Rheum Dis,2009

5. Prevalence of lysosomal storage disorders;Meikle;JAMA,1999

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Umbilical Cord Blood Hematopoietic Cells: From Biology to Hematopoietic Transplants and Cellular Therapies;Archives of Medical Research;2024-09

2. Combination HSCT and intravenous AAV-mediated gene therapy in a canine model proves pivotal for translation of Krabbe disease therapy;Molecular Therapy;2024-01

3. Cord Blood Transplantation for Nonmalignant Diseases;Comprehensive Hematology and Stem Cell Research;2024

4. Hematopoietic stem cell transplant for Hurler syndrome: does using bone marrow or umbilical cord blood make a difference?;Blood Advances;2022-12-13

5. Emerging cellular themes in leukodystrophies;Frontiers in Cell and Developmental Biology;2022-08-08